Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model
Ferro Nguyen, Ivan Alferiev, Peng Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomas
Hiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
March 31, 2009
Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein
Venkatadri Kolla, Linda W Gonzales, Nicole A Bailey, et al.
Oncotarget
|
February 20, 2016
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
Koumudi Naraparaju, Venkatadri Kolla, Tiangang Zhuang, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 14, 2006
Gene induction during differentiation of human pulmonary type II cells in vitro
Kelly C Wade, Susan H Guttentag, Linda W Gonzales, et al.
Cancer Letters
|
February 17, 2015
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma
Radhika Iyer, Jamie L Croucher, Michael Chorny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Trk receptor expression and inhibition in neuroblastomas
Garrett M Brodeur, Jane E Minturn, Ruth Ho, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
Ivan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance
Ivan S Alferiev, David T Guerrero, Peng Guan, et al.
Pediatric Blood & Cancer
|
October 13, 2011
Clinical significance of NTRK family gene expression in neuroblastomas
Jennifer E Light, Hiroshi Koyama, Jane E Minturn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2018
Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model
Ferro Nguyen, Ivan Alferiev, Peng Guan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2012
Mechanisms of CHD5 Inactivation in neuroblastomas
Hiroshi Koyama, Tiangang Zhuang, Jennifer E Light, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
March 31, 2009
Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein
Venkatadri Kolla, Linda W Gonzales, Nicole A Bailey, et al.
Oncotarget
|
February 20, 2016
Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas
Koumudi Naraparaju, Venkatadri Kolla, Tiangang Zhuang, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 14, 2006
Gene induction during differentiation of human pulmonary type II cells in vitro
Kelly C Wade, Susan H Guttentag, Linda W Gonzales, et al.
Cancer Letters
|
February 17, 2015
Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma
Radhika Iyer, Jamie L Croucher, Michael Chorny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
Trk receptor expression and inhibition in neuroblastomas
Garrett M Brodeur, Jane E Minturn, Ruth Ho, et al.
International Journal of Molecular Sciences
|
February 15, 2022
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models
Ivan S Alferiev, David T Guerrero, Danielle Soberman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
February 22, 2022
Poloxamer-linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high-risk neuroblastoma with primary and acquired chemoresistance
Ivan S Alferiev, David T Guerrero, Peng Guan, et al.
Pediatric Blood & Cancer
|
October 13, 2011
Clinical significance of NTRK family gene expression in neuroblastomas
Jennifer E Light, Hiroshi Koyama, Jane E Minturn, et al.
Page
of 3